tradingkey.logo
tradingkey.logo
Suchen

Quest Diagnostics Inc

DGX
Zur Watchlist hinzufügen
188.084USD
-2.096-1.10%
Trading geöffnet ETKurse um 15 Minuten verzögert
20.88BMarktkapitalisierung
20.42KGV TTM

Quest Diagnostics Inc

188.084
-2.096-1.10%

mehr Informationen über Quest Diagnostics Inc Unternehmen

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Quest Diagnostics Inc Informationen

BörsenkürzelDGX
Name des UnternehmensQuest Diagnostics Inc
IPO-datumDec 17, 1996
CEODavis (James E)
Anzahl der mitarbeiter45000
WertpapierartOrdinary Share
GeschäftsjahresendeDec 17
Addresse500 Plaza Drive
StadtSECAUCUS
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07094
Telefon19735202700
Websitehttps://www.questdiagnostics.com/
BörsenkürzelDGX
IPO-datumDec 17, 1996
CEODavis (James E)

Führungskräfte von Quest Diagnostics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
46.45K
+1.80%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
29.57K
-12.98%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.17K
+0.40%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
15.50K
+0.25%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
11.92K
+0.56%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
6.58K
+1.72%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
2.71K
+0.26%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
46.45K
+1.80%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
29.57K
-12.98%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.17K
+0.40%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Routine clinical testing services
5.96B
54.00%
Gene-based and esoteric testing services
4.19B
38.00%
Anatomic pathology testing services
662.10M
6.00%
All other
220.70M
2.00%
COVID-19 testing services
0.00
0.00%
Nach RegionUSD
Name
Umsatz
Anteil
United States
11.04B
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Routine clinical testing services
5.96B
54.00%
Gene-based and esoteric testing services
4.19B
38.00%
Anatomic pathology testing services
662.10M
6.00%
All other
220.70M
2.00%
COVID-19 testing services
0.00
0.00%

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.58%
T. Rowe Price Associates, Inc.
5.54%
Vanguard Portfolio Management, LLC
5.49%
State Street Investment Management (US)
4.86%
Andere
72.07%
Aktionäre
Aktionäre
Anteil
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.58%
T. Rowe Price Associates, Inc.
5.54%
Vanguard Portfolio Management, LLC
5.49%
State Street Investment Management (US)
4.86%
Andere
72.07%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
56.33%
Investment Advisor/Hedge Fund
29.63%
Research Firm
5.13%
Pension Fund
2.82%
Hedge Fund
2.76%
Bank and Trust
1.77%
Sovereign Wealth Fund
1.24%
Individual Investor
0.48%
Family Office
0.06%

Institutionelle Beteiligung

Aktualisiert: Sun, Apr 5
Aktualisiert: Sun, Apr 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
1896
110.61M
99.92%
-3.16M
2025Q4
1760
110.09M
99.89%
--
2025Q3
1807
110.10M
100.22%
-700.93K
2025Q2
1819
110.85M
98.75%
+3.78M
2025Q1
1805
107.66M
97.04%
-1.03M
2024Q4
1782
103.84M
96.80%
+1.47M
2024Q3
1731
102.61M
95.91%
+134.75K
2024Q2
1739
102.41M
97.25%
-2.03M
2024Q1
1743
104.12M
95.50%
-1.89M
2023Q4
1768
101.63M
97.47%
-890.08K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
6.17M
5.62%
+44.49K
+0.73%
Dec 31, 2025
T. Rowe Price Associates, Inc.
6.13M
5.58%
-707.60K
-10.35%
Dec 31, 2025
State Street Investment Management (US)
5.38M
4.9%
+158.62K
+3.04%
Dec 31, 2025
Boston Partners
3.91M
3.56%
-123.56K
-3.06%
Dec 31, 2025
JP Morgan Asset Management
3.74M
3.4%
-38.83K
-1.03%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.03M
2.76%
-8.28K
-0.27%
Dec 31, 2025
Victory Capital Management Inc.
2.13M
1.94%
-217.55K
-9.28%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.93M
1.76%
+24.04K
+1.26%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Healthcare Providers ETF
3.1%
Madison Dividend Value ETF
2.17%
State Street SPDR S&P Health Care Services ETF
1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.81%
First Trust Total US Market AlphaDEX ETF
1.8%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Acruence Active Hedge US Equity ETF
1.26%
First Trust Health Care Alphadex Fund
1.21%
Timothy Plan High Dividend Stock ETF
1.19%
VictoryShares US Value Momentum ETF
1.01%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil3.1%
Madison Dividend Value ETF
Anteil2.17%
State Street SPDR S&P Health Care Services ETF
Anteil1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Anteil1.81%
First Trust Total US Market AlphaDEX ETF
Anteil1.8%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.59%
Acruence Active Hedge US Equity ETF
Anteil1.26%
First Trust Health Care Alphadex Fund
Anteil1.21%
Timothy Plan High Dividend Stock ETF
Anteil1.19%
VictoryShares US Value Momentum ETF
Anteil1.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 1.26B USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 10, 2026
DGX.NB Interim Cash Dividend of gross USD 0.86 paid on Apr 20, 2026 going ex on Apr 06, 2026
Apr 06, 2026
Apr 20, 2026
Apr 06, 2026
Nov 11, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jan 28, 2026 going ex on Jan 13, 2026
Jan 13, 2026
Jan 28, 2026
Jan 13, 2026
Aug 13, 2025
DGX.NB Final Cash Dividend of gross USD 0.8 paid on Oct 20, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Oct 20, 2025
Oct 03, 2025
May 14, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 21, 2025 going ex on Jul 07, 2025
Jul 07, 2025
Jul 21, 2025
Jul 07, 2025
Jan 30, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 21, 2025 going ex on Apr 07, 2025
Apr 07, 2025
Apr 21, 2025
Apr 07, 2025
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Mehr Anzeigen

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI